News Focus
News Focus
icon url

Mufaso

04/14/25 3:08 PM

#255092 RE: DewDiligence #255086

SDGR has an interest in GPCR (Structure Therapeutics). I believe today's rise in SDGR has something to do with GPCR's rise today. Structure's oral small molecule GSBR-1290 is based on a Orforglipron scaffold rather than a Danuglipron Scaffold.